The 154th session of the World Health Organization’s (WHO) Executive Board will take place from 22 January 2024 to 27 January 2024 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading
The USITC has issued a 497 page report on the WTO negotiations over TRIPS and COVID. https://www.usitc.gov/publications/332/pub5469.pdf The USITC release states: The U.S. International Trade Commission (USITC) today released a report about COVID-19 diagnostics and therapeutics and certain flexibilities under… Continue Reading
On October 12, 2023, Knowledge Ecology International (KEI) filed comments regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered T Cell Therapies for the Treatment of Cancer” by the National Institutes of Health (NIH) to… Continue Reading
Summary of September 28, 2023 comments to the TRIPS Council On Paragraph 8 Of The Ministerial Decision On The TRIPS Agreement James Love Knowledge Ecology International (KEI) The June 17, 2022 decision on the TRIPS Agreement and COVID-19 vaccines was… Continue Reading
Knowledge Ecology International (KEI) invites WIPO delegates attending the 35th session of the Standing Committee on the Law of Patents (SCP) to a side event on Tuesday, 17 October 2023. Title: US government FAR 52.227-1 authorizations for non-voluntary use of… Continue Reading
Updates: Senator Sanders Sends Letter to HHS Inspector General Urging Investigation of Exclusive Patent License for NIH-funded Cancer Therapy, Press Release. October 23, 2023. David Dayen, “Sanders Seeks Investigation of NIH Licensing Practices: The senator wants the inspector general to… Continue Reading
These are the slides that were used in a KEI-People’s Vaccine Alliance webinar on delinking R&D financing from temporary monopolies. KEI-PVA-webinar-Delinking-rnd-5oct2023
On October 2, 2023, Knowledge Ecology International submitted written comments to the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Medicare Price Negotiation public consultation process. CMS is hosting a series of patient-focused listening sessions this fall,… Continue Reading
Today, Knowledge Ecology International (KEI) submitted a letter to the Commissioner of the Food and Drug Administration (FDA) regarding the mismatch between the cost to perform pediatric extension trials and the cost to the public of the six month extension… Continue Reading